Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases
about
Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases.Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies.The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factorsMucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.Impact of Intestinal Ultrasound on Classification and Management of Crohn's Disease Patients with Inconclusive Colonoscopy.Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease.Update on the Medical Management of Crohn's Disease.Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn's disease.Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.Frontiers in Drug Research and Development for Inflammatory Bowel Disease.Clinic-based Point of Care Transabdominal Ultrasound for Monitoring Crohn's Disease: Impact on Clinical Decision Making.Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.Could early anti-tumor necrosis factor therapy change the prognosis of Crohn's disease?The prognostic value of histology in ulcerative colitis in clinical remission with mesalazineValidity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn's Disease.Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.Food Elimination Diet and Nutritional Deficiency in Patients with Inflammatory Bowel Disease.New Trends in Inflammatory Bowel Disease.Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis.Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis.Anti-TNF Withdrawal in Inflammatory Bowel Disease.UEG Week 2015 Poster Presentations
P2860
Q35193565-AEE9215C-3853-4FD2-93F4-45F08CC4810CQ35627602-1FFC6200-3333-4CB2-9D01-0733E6C5B75FQ36095803-5198153F-6AE2-4547-8D72-B6789734B94CQ36172156-AF759FFC-4597-49B9-ABC0-9DEFD8EF6967Q36380315-72ECC9B3-7670-4298-800E-2649AEE85B23Q36578893-F200DE5B-3B9B-498B-A1A0-105E3FAF776CQ36997080-27008952-C1B1-4E35-AB2E-78039A2AE3ECQ38365049-6DC0B638-8C3C-46F2-9760-672A7C3D53D1Q38585634-BA5C5D1C-3980-4653-9E31-15376A1FD09FQ38726458-0790663F-A6F9-41F1-8C37-05B29D598F17Q38816194-E6D3863E-8AA0-4023-AEB4-7B98BA808A79Q39120033-0EF53E21-0CEA-4FD3-B4DC-686F95B5411CQ39424463-6CA3C445-75B4-446B-BA7F-D4B1B15330D9Q40830755-8925BCFE-8834-40B0-9400-FEB5730CF3C9Q41329796-EDC80C9C-CA03-4C27-ADF0-38FF6DB2CF4AQ41905172-17C4AA3A-2796-4B7D-A20C-2CB0D1D539A0Q42375644-747812EE-FA57-4466-8FF7-74417E3C4E7AQ47598080-DFCD3DF6-2989-44BB-93EE-B3CE4189DCDDQ47747881-6D7FF7E3-8DEE-404D-ABF0-4D298F24F6CAQ47932426-1AE24664-9041-4609-92C9-D53575550023Q49776023-AE6A9D80-B52A-4209-B6E1-00B133D4B5DCQ50979274-41808779-8685-41FF-AA7A-05566A6BE41FQ51647910-F4FB9152-7112-495F-B838-6CE51558A06EQ53827365-F9A40F14-5767-4C54-BFD1-2F82FFE8398EQ55421713-B838F6BC-CE9A-43E4-96C5-CA629E175A74Q56934656-511D44A1-FC71-4DFB-999F-F06054F635FB
P2860
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Treating beyond symptoms with ...... in inflammatory bowel diseases
@ast
Treating beyond symptoms with ...... in inflammatory bowel diseases
@en
Treating beyond symptoms with ...... in inflammatory bowel diseases
@nl
type
label
Treating beyond symptoms with ...... in inflammatory bowel diseases
@ast
Treating beyond symptoms with ...... in inflammatory bowel diseases
@en
Treating beyond symptoms with ...... in inflammatory bowel diseases
@nl
prefLabel
Treating beyond symptoms with ...... in inflammatory bowel diseases
@ast
Treating beyond symptoms with ...... in inflammatory bowel diseases
@en
Treating beyond symptoms with ...... in inflammatory bowel diseases
@nl
P2093
P2860
P50
P921
P3181
P1476
Treating beyond symptoms with ...... in inflammatory bowel diseases
@en
P2093
Joel Petersson
Remo Panaccione
Stephanie Wilson
Stephen Hanauer
P2860
P304
P3181
P356
10.1016/J.CROHNS.2014.02.021
P407
P577
2014-09-01T00:00:00Z